C. O. Truxton Inc

Form 483 issued June 1, 2017 · Bellmawr, New Jersey

Inspection
Apr 17 – Jun 1, 2017
Investigator
Nancy M. Espinal
Observations
11
Pages
6
FEI number
2220338

In short: On June 1, 2017, FDA issued a Form 483 with 11 observations to C. O. Truxton Inc in Bellmawr, New Jersey (FEI 2220338) after an inspection that ran Apr 17 – Jun 1, 2017. The investigator was Nancy M. Espinal. Most observations concern quality system and packaging & labeling.

At a glance

Observations span 4 systems, led by quality system.

Quality system3
Packaging & labeling3
Facilities & equipment2
Laboratory controls1
Other2

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is no quality…

  2. 02

    GMP training is not conducted to assure that employees remain familiar with CGMP…

  3. 03

    Procedures describing the handling of written and oral complaints related to drug products are…

  4. 04

    There is no written testing program designed to assess the stability…

7 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at C. O. Truxton Inc?

FDA listed 11 observations on this Form 483, mostly about quality system, packaging & labeling and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected C. O. Truxton Inc?

Nancy M. Espinal is named on this Form 483, for the inspection of Apr 17 – Jun 1, 2017. Each investigator has a profile showing what they cite most.

When was C. O. Truxton Inc inspected by FDA?

The inspection ran Apr 17 – Jun 1, 2017, and the Form 483 is dated June 1, 2017.

How do I get the full Form 483 for C. O. Truxton Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free